• Our company
    • Overview
    • Leadership
    • Scientific Advisory Board
    • Board of Directors
    • Investors
  • Technology
    • Autologous ex-vivo gene therapy
    • The scientific advantage
  • R&D programmes
    • Overview
    • ADA-SCID
    • X-CGD
    • MPS-IIIA
    • MPS-IIIB
    • Follow-on programmes
  • News
    • 2018
    • 2017
  • Join us
  • Contact us

Latest news

Archives

2018
  • April
  • March
  • February
  • January
2017
  • December
  • November
  • September
  • August
  • July
  • May
  • January
2016
  • November
  • October
  • September
  • August
  • May
Orchard Therapeutics announces the opening of US operations in Foster City, California

06 October 2016
Read more
© 2018 Orchard Therapeutics. All Rights Reserved. Registered in England - Registration number (Companies House): 09759506
Our registered address is: Birchin Court, 20 Birchin Lane, EC3V 9DU London UK.